These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 16504918)

  • 41. Potential therapeutic targets for idiopathic inflammatory myopathies.
    De Bleecker JL; Creus KK; De Paepe B
    Drug News Perspect; 2006 Nov; 19(9):549-57. PubMed ID: 17220960
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous immunoglobulin treatment for pregnancy-associated dermatomyositis.
    Linardaki G; Cherouvim E; Goni G; Boki KA
    Rheumatol Int; 2011 Jan; 31(1):113-5. PubMed ID: 19844719
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trial of Intravenous Immune Globulin in Dermatomyositis.
    Aggarwal R; Charles-Schoeman C; Schessl J; Bata-Csörgő Z; Dimachkie MM; Griger Z; Moiseev S; Oddis C; Schiopu E; Vencovský J; Beckmann I; Clodi E; Bugrova O; Dankó K; Ernste F; Goyal NA; Heuer M; Hudson M; Hussain YM; Karam C; Magnolo N; Nelson R; Pozur N; Prystupa L; Sárdy M; Valenzuela G; van der Kooi AJ; Vu T; Worm M; Levine T;
    N Engl J Med; 2022 Oct; 387(14):1264-1278. PubMed ID: 36198179
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HIV-associated nemaline rod myopathy: role of intravenous immunoglobulin therapy in two persons with HIV/AIDS.
    de Sanctis JT; Cumbo-Nacheli G; Dobbie D; Baumgartner D
    AIDS Read; 2008 Feb; 18(2):90-4. PubMed ID: 18330038
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of intravenous immune globulin in the therapy of children with rheumatological diseases.
    Roifman CM
    J Clin Immunol; 1995 Nov; 15(6 Suppl):42S-51S. PubMed ID: 8613492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Established and new therapeutic approaches in dermatomyositis, polymyositis and overlapping syndromes].
    Göttfried I; Seeber A; Anegg B; Pirkhammer D; Rieger A; Stingl G; Volc-Platzer B
    Wien Klin Wochenschr; 1996 Nov; 108(22):705-16. PubMed ID: 9157716
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A pilot trial of rituximab in the treatment of patients with dermatomyositis.
    Chung L; Genovese MC; Fiorentino DF
    Arch Dermatol; 2007 Jun; 143(6):763-7. PubMed ID: 17576943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.
    Daoud YJ; Amin KG
    Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of intravenous infusions of gamma globulin in the therapy of polymyositis and dermatomyositis.
    Sussman GL; Pruzanski W
    J Rheumatol; 1994 Jun; 21(6):990-2. PubMed ID: 7932446
    [No Abstract]   [Full Text] [Related]  

  • 50. Inflammatory myopathies: evaluation and management.
    Greenberg SA
    Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dermatomyositis: diagnosis, evaluation and management.
    Callen JP
    Minerva Med; 2002 Jun; 93(3):157-67. PubMed ID: 12094147
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Active or passive immunization in unexplained recurrent miscarriage.
    Christiansen OB; Nielsen HS; Pedersen B
    J Reprod Immunol; 2004 Jun; 62(1-2):41-52. PubMed ID: 15288180
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of intravenous immunoglobulin in multifocal motor neuropathy.
    Leger JM; Vargas S; Lievens I
    Ann N Y Acad Sci; 2007 Sep; 1110():248-55. PubMed ID: 17911439
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The use of intravenous immunglobulin in the treatment of autoimmune neuromuscular diseases].
    Molnár MJ
    Ideggyogy Sz; 2006 Mar; 59(3-4):98-106. PubMed ID: 16634454
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-dose immunoglobulin therapy for a patient with dermatomyositis.
    Furuya Y; Takahashi T; Hamamoto H; Nishimura M; Kawakami Y
    Intern Med; 1998 Jul; 37(7):642-5. PubMed ID: 9711898
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis.
    Saito E; Koike T; Hashimoto H; Miyasaka N; Ikeda Y; Hara M; Yamada H; Yoshida T; Harigai M; Ichikawa Y
    Mod Rheumatol; 2008; 18(1):34-44. PubMed ID: 18217197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials.
    Wedderburn LR; Varsani H; Li CK; Newton KR; Amato AA; Banwell B; Bove KE; Corse AM; Emslie-Smith A; Harding B; Hoogendijk J; Lundberg IE; Marie S; Minetti C; Nennesmo I; Rushing EJ; Sewry C; Charman SC; Pilkington CA; Holton JL;
    Arthritis Rheum; 2007 Oct; 57(7):1192-201. PubMed ID: 17907237
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis.
    Grundtman C; Tham E; Ulfgren AK; Lundberg IE
    Arthritis Rheum; 2008 Oct; 58(10):3224-38. PubMed ID: 18821695
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Dysimmune and inflammatory myopathies].
    Authier FJ
    Rev Prat; 2008 Dec; 58(20):2253-60. PubMed ID: 19209656
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial.
    Hughes RA
    Expert Rev Neurother; 2009 Jun; 9(6):789-95. PubMed ID: 19496683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.